Chemical Diagram (Chemical)
Chemical structure of finafloxacin, the active ingredient in XTORO otic suspension 3 mg/mL.*
Xtoro Suspension
Product Images NDC 83709-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Xtoro (NDC 83709-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fonseca Biosciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure1)
An instructional illustration showing hands holding a small bottle with a dropper tip, demonstrating how to hold the container, presumably for administering XTORO (finafloxacin) otic suspension. The image is labeled as Figure 1.*
Figure 2 (Figure2)
An illustration showing a person lying on their side with the ear facing upward, likely demonstrating a position for auricular (otic) suspension administration or ear treatment.*
Figure 3 (Figure3)
An instructional illustration demonstrating administration of ear drops by placing a drop into the ear canal of a person lying down with their head tilted. The image shows a hand holding a dropper bottle above the ear, dispensing a liquid drop.*
Figure 4 (Figure4)
An instructional illustration labeled Figure 4, showing a hand administering auricular (otic) suspension into the ear canal. The diagram highlights correct application technique relevant to ear medication delivery.*
Carton (New Carton)
Packaging label for XTORO (finafloxacin otic suspension) 0.3%, a sterile 5 mL suspension for topical use in the ear. The label notes the dosage form as suspension with instructions to warm the bottle in hands and shake well before using. Manufactured for Fonseca Biosciences, LLC, with storage instructions to keep at 2°C to 25°C (36°F to 77°F) and not to freeze. Active ingredient concentration is 3 mg/mL.*
Bottle (New Container)
Label of XTORO (finafloxacin otic suspension) 0.3%, an auricular suspension with 3 mg/mL finafloxacin active ingredient. The label includes storage instructions at 2°C to 25°C, states sterile 5 mL quantity, and notes Rx only. Manufactured for Fonseca Biosciences, LLC.*
Bottle-sample-1-5 (Sample Bottle 1 5)
Label of XTORO (finafloxacin otic suspension) 0.3%, an auricular suspension with a concentration of 3 mg/mL finafloxacin. The label indicates it is a sterile 1.5 mL dose, Rx only, manufactured for Fonseca Biosciences, LLC. Storage instructions specify to store between 2°C and 25°C and not to freeze. The product is noted as a sample, not for sale, and includes lot and expiration date fields.*
Sample-bottle-5 (Sample Bottle 5)
Label for XTORO finafloxacin otic suspension 0.3% (3 mg/mL) in a 5 mL bottle. It is a sterile human prescription drug for auricular use, manufactured for Fonseca Biosciences, LLC. The label notes storage instructions (2°C-25°C), cautions against freezing, and indicates the product is a sample not for sale. Includes NDC 83709-001-91 and markings for lot and expiration dates.*
Carton-sample-1-5 (Sample Carton 1 5)
XTORO 0.3% finafloxacin otic suspension packaging label shows it is a sterile suspension for topical use in the ear, containing 3 mg/mL finafloxacin. The label highlights sample status, manufacturer Fonseca Biosciences, LLC, and includes instructions to warm the bottle in hands and shake well before using. Storage instructions specify 2°C-25°C (36°F-77°F) and advise not to freeze. The package volume is 1.5 mL.*
Sample-carton-5 (Sample Carton 5)
Packaging label for XTORO (finafloxacin otic suspension) 0.3%, a prescription auricular suspension in a 5 mL dose. The label shows the product name, active ingredient, strength, route, and volume. It includes manufacturer and labeler information for Fonseca Biosciences, LLC, with storage instructions and a barcode. The label also notes it is for topical use in the ear and indicates the product of Spain.*
Pouch-sample-1-5 (Sample Pouch 1 5)
Label for XTORO (finafloxacin otic suspension) 0.3%, a sterile 1.5 mL otic suspension. The label includes storage instructions (2°C-25°C, do not freeze), states it is Rx only, and indicates topical use in the ear. Manufactured for Fonseca Biosciences, LLC, Long Beach Township, NJ. The NDC number 83709-001-90 is visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
